Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033313 · ClinicalTrials.gov registry record · NA
Effects of Framing on Medication Beliefs, Intentions to Take Medication, Adherence, and Asthma Control
A NA study, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT06033313 is a NA study that has completed, run by Auburn University. The registered enrollment target is 43 participants.
The verdict
NCT06033313, a NA study, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The goal of this study is to examine the effects of framed mobile messages on young adults' beliefs about their daily Inhaled Corticosteroids (ICS), intentions to take their ICS, adherence, and asthma control. College students (18-29 years) who owned a mobile phone and had a diagnosis of asthma with a prescription for an ICS will be recruited. Participants will be randomized to receive either gain- or loss-framed mobile messages three times per week for eight weeks. Outcomes including beliefs, intentions, adherence, and asthma control will be assessed.
Interventions
- BEHAVIORAL Negatively Framed text messages
- BEHAVIORAL Positively Framed text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2019-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06033313
The ClinicalTrials.gov registry entry for NCT06033313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Negatively Framed text messages is the first listed.
NCT06033313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06033313 about?
NCT06033313 is a clinical study titled "Effects of Framing on Medication Beliefs, Intentions to Take Medication, Adherence, and Asthma Control". The goal of this study is to examine the effects of framed mobile messages on young adults' beliefs about their daily Inhaled Corticosteroids (ICS), intentions to take their ICS, adherence, and asthma control. College students (18-29 years) who owned a mobile phone and had a diagnosis of asthma with...
What is the current status of trial NCT06033313?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2019-10-01. Estimated completion is 2019-11-30.
What interventions are being tested in trial NCT06033313?
The interventions under investigation include: Negatively Framed text messages (BEHAVIORAL), Positively Framed text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT06033313?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.